Formularies continue to increase in complexity, and changes to those formularies are especially challenging for consumers to navigate.

And other pharma news rounded up from around the Pharmalot campus, as told to you by the Pharmalittle newsletter ...

With appreciation for feedback from Mark Fendrick, Director of the Value-Based Insurance Design (V-BID) Center at the University of Michigan, and Daneen Seekoni, Vice President of Policy and Advocacy ...

Optum Rx, a pharmacy benefit manager owned by one of the country’s largest insurance companies, UnitedHealth Group, has added a new, much-anticipated pain drug to some of its commercial formularies.

Pharmacies will be the canary in the coal mine for the Medicare Drug Price Negotiation Program, writes Sujith Ramachandran.

The U.S. healthcare system is the best in the world for complex care. We have the most innovative drug companies, the best medical devices, and incredible doctors and surgeons. The U.S. healthcare ...

Discover why Harrow Inc. (HROW) is a strong buy in 2024—explosive growth from Vevye, rising margins, and a $175 price target.

Prescription drug prices are a major concern for people, healthcare professionals, and policymakers. Even for those with insurance, out-of-pocket costs can still be high. Several factors contribute to ...

Many Medicare recipients are benefiting from changes that make prescriptions more affordable. But you can still make other moves to keep your costs in check.

Compounding is the act of mixing, combining, or altering ingredients to tailor a medication to an individual’s needs. Generally, compounding a medication is done by a licensed pharmacist, a licensed ...

As China's aging population increases demand for therapies treating everything from cancer and diabetes to dementia, the ...